1,065,608 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Purchased by Norges Bank
Norges Bank bought a new position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 1,065,608 shares of the company’s stock, valued at approximately $21,717,000. Several other hedge funds also recently made changes to their […]
